GPR65 blockade may not uniformly remodel immune landscapes across all tumour regions and could inadvertently support cancer stem cell niches or create selection pressures that confer survival advantages to more aggressive cancer cells [97,99]. This evidence concerns the gene GPR65 and cancer.